Design a site like this with WordPress.com
Get started

Surgical Sealants And Adhesives Market: Heart Transplant Procedures is Expected To Contribute To The Growth

Surgical Sealants and Adhesives Industry Overview

The global surgical sealants and adhesives market size was valued at USD 1.82 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2022 to 2030. Sealants and adhesives have evolved to become useful accompaniments in modern surgical procedures. They are widely preferred because of their safety, efficacy, and usability in repairing injured tissues and supporting wounds obtained during surgery. The pandemic caused by COVID-19 across the globe resulted in nationwide lockdowns and exerted pressure on the healthcare settings. According to the list provided by the American College of Surgeons, all dental, medical, or surgical procedures that are nonessential and elective in nature were postponed, except for medical emergencies.

Factors contributing to the growth of this market are the rising demand for surgical services and increasing concerns to reduce surgical wounds. Globally, the number of surgeries being undertaken has increased significantly. According to the WHO estimations, approximately, 235 million major surgical procedures are undertaken worldwide every year. Surgical procedures are normally accompanied by the risk of wound infection, excessive bleeding, or tissue damage. In addition, patients suffering from diabetes need to be extra cautious as the chances of complications during and post-surgery are significantly higher in their case.

As the volume of surgeries is increasing, extensive R&D activities focused on the widening applications of surgical sealants and adhesives are also rising. Traditional alternatives to surgical sealants are sutures and staples, which are expected to be replaced by surgical sealants and adhesives owing to their better wound closure capabilities with minimal blood loss. The sealants facilitate less painful operations and do not need removal. Currently, sealants are facing limited market growth owing to their high costs. In addition, strict regulatory approvals are creating substantial challenges in market growth.

Gather more insights about the market drivers, restrains and growth of the Global surgical sealants and adhesives market

Browse through Grand View Research’s Medical Devices Industry Research Reports.

  • Buccal Drug Delivery Systems Market – The global buccal drug delivery systems market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028.

  • Dental Articulators Market – The global dental articulators market size was valued at USD 126.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028.


Surgical Sealants And Adhesives Market Segmentation

Grand View Research has segmented the global surgical sealants and adhesives market on the basis of type, application, and region:

Surgical Sealants And Adhesives Type Outlook (Revenue, USD Million, 2018 – 2030)

  • Natural or Biological Adhesives and Sealants 
    • Fibrin Sealants
    • Collagen Based Adhesives
    • Gelatin Based Adhesives
  • Synthetic and Semi-synthetic Adhesives and Sealants 
    • Cyanoacrylates
    • Polymeric Hydrogels
    • Urethane Based Adhesives

Surgical Sealants And Adhesives Application Outlook (Revenue, USD Million, 2018 – 2030)

  • Central Nervous System
  • Cardiovascular
  • General Surgery
  • Orthopedic
  • Pulmonary
  • Urology
  • Ophthalmology
  • Others

Surgical Sealants And Adhesives Regional Outlook (Revenue, USD Million, 2018 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)


Key Companies profiled:

Some prominent players in the global surgical sealants and adhesives market include:

  • Baxter International, Inc.
  • CryoLife, Inc.
  • C.R. Bard, Inc.
  • Medtronic PLC
  • B. Braun Melsungen AG
  • Cohera Medical, Inc.
  • Ethicon, Inc. [J&J]
  • Mallinckrodt plc
  • Cardinal Health
  • Integra LifeSciences Holdings Corporation

Order a free sample PDF of the Surgical Sealants And Adhesives Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Europe Orthopedic Navigation Systems Market Size, Share & Trends Analysis Report 2022 – 2030

Europe Orthopedic Navigation System Industry Overview

The Europe orthopedic navigation systems market size was valued at USD 634.3 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.9% from 2022 to 2030. Rising incidences of osteoarthritis and demand for minimally invasive surgeries for joint replacement surgery are expected to boost the demand for surgical navigation systems over the forecast period. Rising expenditure on healthcare, awareness about computer-assisted surgical navigation systems, and adoption of these techniques are some factors expected to contribute to market growth in the forthcoming years.

The market has been adversely impacted by the COVID-19 lockdown scenario. The COVID-19 outbreak negatively impacted the elective surgical procedure demand and thereby restricted the growth of the market in Europe. Disruption in the supply chain, inter-country travel restrictions, and slow economic growth resulted in a decline from previous years. As the restriction on elective surgeries lifted post lockdown, the demand for orthopedic navigation systems is set to rise. Orthopedic clinics started with a limited number of elective procedures as the COVID-19 cases began decreasing, which is expected to propel the market growth.

Gather more insights about the market drivers, restrains and growth of the Europe Orthopedic Navigation System market

The European Commission estimates around 20% of the population to be aged above 60 years in 2025. Women are more prone to degenerative joint disorders as compared to men post the age of 50. The total age dependency ratio in Europe is expected to rise to 77.9% by 2080 and the age dependency ratio in 28 EU countries is projected to increase to around 51%. The growing geriatric and obese population prone to hip fractures and degenerative joint disorders is anticipated to create growth opportunities for orthopedic navigations systems in near future.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Nephrostomy Devices Market – The global nephrostomy devices market size was valued at USD 940.26 million in 2018 and is anticipated to expand at a CAGR of 7.8% from 2019 to 2026. Increasing cases of kidney stone disorder, a rise in demand for minimally invasive surgical procedures, and increased awareness about the product are a few factors driving the market.

  • Cranial Implants Market – The global cranial implants market size was valued at USD 991.80 million in 2018 and is anticipated to expand at a CAGR of 6.4% by 2026. Increasing prevalence of neurological diseases, injuries, wounds, and road accidents coupled with rising awareness among professionals is anticipated to propel the growth.

Europe Orthopedic Navigation Systems Market Segmentation

Grand View Research has segmented the Europe orthopedic navigation systems market based on application, end-use, and country:

Europe Orthopedic Navigation Systems Application Outlook (Revenue, USD Million, 2017 – 2030)

  • Knee
  • Hip
  • Spine

Europe Orthopedic Navigation Systems End-use Outlook (Revenue, USD Million, 2017 – 2030)

  • Hospitals
  • Ambulatory Surgical Centers

Key Companies profiled:

Some of the prominent players in the Europe orthopedic navigation systems market include:

  • B. Braun Melsungen AG
  • Stryker
  • Medtronic
  • Brainlab AG
  • Johnson & Johnson Services, Inc. (DePuy Synthes)
  • Zimmer Biomet
  • MicroPort Medical
  • Orthokey Italia SRL.
  • Amplitude

Order a free sample PDF of the Europe Orthopedic Navigation System Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Fixed And Mobile C-Arms Market: North America Dominated And Accounted For The Largest Revenue Share

Fixed And Mobile C-arms Industry Overview

The global fixed and mobile C-arms market size was valued at USD 2.02 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030. The market growth can be attributed to the growing number of surgical procedures, and technological advancements in the development of novel C-arms. In addition, the rising geriatric population, which is susceptible to various chronic disorders, is also expected to contribute to the market growth.

The use of C-arm systems in intraoperative procedures has become an important tool in modern surgical practice. It enhances the technical proficiency of the surgeon in addition to reducing the morbidity and patient’s duration/length of stay (LOS) in the hospital. The powerful imaging system on the C-arm allows for many movements to be performed in a single session. C-arm machines are widely utilized in orthopedic, urology, gastrointestinal, pain management, cardiovascular, emergency, and therapeutic studies such as stent or needle placements.

Gather more insights about the market drivers, restrains and growth of the Global Fixed And Mobile C-arms market

Many market players make constant efforts to develop advanced systems, such as the integration of Artificial Intelligence (AI)-enabled technology and 3D mapping capabilities in a C-arm system, which would improve process planning, increase real-time intraoperative guidance, and considerably reduce surgical operation times. For instance, in January 2022, Philips announced the integration of cloud-based AI and 3D mapping into its mobile C-arm System Series – Zenition – to enhance workflow efficiency and improve endovascular treatment outcomes. Philips further stated that the combination of these technologies would result in a 50% reduction in radiation exposure and a more than 20% reduction in procedure times.

The rising geriatric population susceptible to various chronic conditions such as cardiovascular, orthopedic, and respiratory diseases, coupled with increasing patient awareness, is expected to drive the market growth over the forecast period. According to the WHO, the population of people aged 60 years and above will be about 2.1 billion by 2050 from 1.5 billion in 2020. In addition, the increasing level of accuracy with 3D visualization and the introduction of flat-panel detectors replacing image intensifiers, which lowers patient dose and increases image quality, has led to increasing demand for these devices in recent years, allowing healthcare experts to understand the intensity of a disease better.

The COVID-19 pandemic negatively impacted the C-arms market, since these systems are used in guidance for mostly elective surgeries. Studies suggest that about 28 million elective procedures may be canceled around the world during the COVID-19 pandemic’s peak disruption period of 12 weeks. However, the elective surgery rate has increased by one-fifth after the lockdown and also decreased elective surgery waiting times by as much as one-third, thus creating opportunities for market expansion.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Tumor Ablation Market – The global tumor ablation market size was valued at USD 1.14 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2022 to 2030.
  • Tracheostomy Products Market – The global tracheostomy products market size was valued at USD 193.8 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period from 2022 to 2030.

Fixed And Mobile C-arms Market Segmentation

Grand View Research has segmented the global fixed and mobile C-arms market based on product, application, and region:

Fixed And Mobile C-arms Product Outlook (Revenue, USD Million, 2017 – 2030)

  • Fixed C-arms
  • Mobile C-arms
    • Full-size C-arms
    • Mini C-arms

Fixed And Mobile C-arms Application Outlook (Revenue, USD Million, 2017 – 2030)

  • Orthopedics and Trauma
  • Neurosurgery
  • Cardiovascular
  • Pain Management
  • Gastroenterology
  • Others

Fixed And Mobile C-arms Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • March 2021: GE Healthcare received FDA clearance for its OEC 3D, a surgical imaging C-arm system capable of 3D and 2D imaging.


Key Companies profiled:

Some of the prominent players in the global fixed and mobile C-arms market include:

  • GE Healthcare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V. 
  • Medtronic
  • Ziehm Imaging GmbH
  • Shimadzu Corporation
  • Hologic Corporation
  • Canon Medical Systems
  • FUJIFILM
  • Eurocolumbus


Order a free sample PDF of the Fixed And Mobile C-arms Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Continuous Renal Replacement Therapy Market: North America Dominated And Accounted For The Highest Revenue Share

Continuous Renal Replacement Therapy Industry Overview

The global continuous renal replacement therapy market size was valued at USD 1.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2022 to 2030. Rising incidence of Acute Kidney Injury (AKI), increasing incidence of sepsis, rapid increase in volume of hospitals and urgent care centers, growing hospital admissions rate, and constant product launches by prominent market players are few factors driving the demand for CRRT, thereby propelling market growth. In the pre-COVID-19 era, the burden of COVID-19-associated AKI climbed to almost 4 million cases per year.

As a result, the high number of COVID-19 patients who develop AKI is expected to drive the market for continuous renal replacement therapy over the forecast period. CRRT was utilized to treat roughly 23,105 AKI patients per year prior to COVID-19. The need for CRRT appears to be 5 times higher in COVID-19 patients, i.e., 4.9 percent, then in historical populations (0.9 percent). In community cohort datasets, 5%–15% of people hospitalized with COVID-19 needed dialysis. Moreover, in some North America regions, the number of people utilizing CRRT jumped by 370 percent over normal levels due to which the demand for the product has been increased during pandemic.

Gather more insights about the market drivers, restrains and growth of the Global Continuous Renal Replacement Therapy market

Furthermore, high number of initiatives taken by the manufacturers and government during the pandemic to increase awareness regarding CRRT and CKD is expected to boost the growth of the market for continuous renal replacement therapy. For instance, Fresenius Medical Care North America’s Renal Therapies Group (FMCNA) released the first batch of multiBic dialysate solutions to U.S. hospitals in May 2020, according to an FDA emergency use authorization. These medicines are intended to provide CRRT to COVID-19-related individuals with acute renal failure.

Furthermore, the pandemic of COVID-19 has also led in a surge in demand for CRRT in the worldwide. As a result, the market for continuous renal replacement therapy has seen an increase in financial incentives as well as regulatory support from various government agencies. These factors are expected to contribute to the CRRT market’s positive growth in the worldwide over the forecast period. Moreover, several studies are being undertaken across the worldwide to assess the demand for CRRT during a pandemic. In February 2021, the journal Kidney360 released a research titled “Meeting the Demand for Renal Replacement Therapy During the COVID-19 Pandemic: A Manufacturer’s Perspective.” The study looked at the influence of COVID-19 on the CRRT market as well as the link between AKI and COVID-19-affected patients.

AKI was diagnosed in 28 percent to 46 percent of COVID-19 hospitalized patients, according to major U.S. cohorts studied at the onset of the pandemic. Patients requiring admission/transfer to the ICU had significantly higher rates, ranging from 61 percent to 78 percent. Going forward, as lockdown restrictions are being lifted in most of the countries, supply chains of most healthcare companies, including CRRT, are expected to work effectively and smoothly over the forecast period. Thus, the market for continuous renal replacement therapy is expected to grow at a significant rate in the coming years. Moreover, the COVID-19 outbreak has created opportunities for local manufacturers. These firms are adopting various plans and policies to gain a higher market share. Players are partnering with relevant third-party vendors to reinforce their foothold in the market.

The rising prevalence of fluid overload, which is common in AKI patients in critical care units, is increasing demand for CRRT devices. In addition, the FDA has imposed tight regulations requiring manufacturers to ensure the availability of high-quality CRRT devices in intensive care units. Due to COVID-19 pandemic, rate of kidney infections has been increased due to which several CRRT devices such as hemofilter / hemodialyzer, delivery unit, dialysate solution, and bloodlines and tubing have been authorized by FDA for emergency use in COVID-19 patients. For instance, Prismaflex HF20 Set and Prismaflex ST Set by Baxter Healthcare Corporation and multiFiltrate PRO System and multiBic/multiPlus Solutions by Fresenius Medical are specific CRRT and hemodialysis devices authorized by FDA. Thus, COVID-19 is contributing to increase in the demand for CRRT devices during the forecast period.

The increased demand for advanced CRRT devices as a result of improved patient outcomes is a high-impact major driver of the market for continuous renal replacement therapy. The current CRRT technology has made it possible to analyze and respond to technical data in a complete manner. These improvements have resulted in a detailed examination of prescription and delivery patterns, which has had a favorable impact on clinical results from the standpoint of quality assurance. The most recent CRRT machines allow for automated data gathering and uniform language, allowing for cross-institutional comparisons. Several major market manufacturers have introduced sophisticated CRRT machines that use these technologies which is expected to boost the growth of the market.

Furthermore, the development of improved pediatric CRRT products is projected to the market for continuous renal replacement therapy in the near future. Pediatric patients who require CRRT have traditionally been treated with systems that are created and indicated for adults and are not licensed for pediatric usage, which can lead to clinical problems in neonates. As a result, various manufacturers currently offer a range of renal care solutions that enhance access to care, results, and quality of life for patients with severe renal disease or injury anywhere in the globe, regardless of their size or age, which is projected to fuel market expansion.

For instance, December, 2020, the pediatric dialysis emergency machine which is named as Carpediem Cardio-Renal has been commercially launched in the U.S by Medtronic plc. This technology is indicated for use in patients who require hemofiltration or hemodialysis therapy due to acute renal fluid overload or damage. It’s designed to give patients who weigh among 2.5 and 10 kilos Continuous Renal Replacement Therapy (CRRT). U.S dominated the market for continuous renal replacement therapy with the highest shares. This can be attributed to rising prevalence of Acute Kidney Injury (AKI) and presence of large number of hospitals in the U.S., coupled with well-developed healthcare infrastructure.

For instance, according to American Hospital Association in 2021, there were 5,141 community hospitals, 625 nonfederal psychiatric hospitals, and 208 federal government hospitals in the U.S. In addition, significant increase in the number of hospital admissions for AKI along with the increasing geriatric populations is boosting the demand for CRRT systems, thereby propelling market growth. Moreover, according to According to the Centers for Disease Control and Prevention’s in 2021, nearly 786,000 people in the U.S are living with ESKD, also known as end-stage renal disease (ESRD), with 71% on dialysis and 29% with a kidney transplant. Thus, with rising prevalence of end-stage renal disease, the number of dialysis clinics and treatment centers is growing. For instance, as of 2020, there were around 7,500 dialysis clinics in the U.S. This factor is expected to positively impact market growth in the U.S.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Hospital Bedsheet & Pillow Cover Market – The global hospital bedsheet & pillow cover market size was valued at USD 4,586.9 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028.

  • Blood Ketone Meter Market – The global blood ketone meter market size was valued at USD 279.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2028.


Continuous Renal Replacement Therapy Market Segmentation

Grand View Research has segmented the global continuous renal replacement therapy market on the basis of product, modality, and region:

Continuous Renal Replacement Therapy Market, Product Outlook (Revenue USD Million; 2017 – 2030)

  • System
  • Consumables

Continuous Renal Replacement Therapy Market, Modality Outlook (Revenue USD Million; 2017 – 2030)

  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

Continuous Renal Replacement Therapy Market, Age Group Outlook (Revenue USD Million; 2017 – 2030)

  • Adults
  • Pediatrics /Neonates

Continuous Renal Replacement Therapy Market, End Use Outlook (Revenue USD Million; 2017 – 2030)

  • Hospitals
  • Ambulatory Centers
  • Specially Clinics
  • Others

Continuous Renal Replacement Therapy Market, Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • March 2021: B. Braun Avitum AG, a manufacturer of pharmaceutical and medical devices services and products, have stated the launch of a global co-marketing contract with B. Braun’s latest OMNIset Plus bloodline set (set version 3.0 or higher) and continuous purification of blood (OMNI) platform to support the use of CytoSorb.
  • June 2021: Fresenius Medical Care inaugurated its training center in Korea, to support education for healthcare professionals in critical care, renal care, and treatment strategies.



Key Companies profiled:

Some of the prominent players in the continuous renal replacement therapy market include:

  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Corporation
  • NIPRO Corporation
  • Toray Medical Co., Ltd
  • NxStage Medical, Inc.
  • Medtronic plc & Others

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Disposable Blood Pressure Cuffs Market: Clinician’s Segment is Expected To Witness Exponential Growth At A 12.4% Compound Annual Growth Rate

Disposable Blood Pressure Cuffs Industry Overview

The global disposable blood pressure cuffs market size was valued at USD 249.77 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 12.02% from 2022. Increasing incidences of hypertension due to changing lifestyles are contributing to the disposable blood pressure (BP) cuffs market growth during the forecast period. Moreover, the demand for disposables BP cuffs is very high on account of the growing elderly population and increasing risk of lifestyle associated disorders among a wide population due to the rising incidences of obesity and sedentary lifestyle.

In addition, the increasing incidence of cross contaminations in healthcare facilities is another key contributing factor driving the market growth. As per World Health Organization (WHO), healthcare-associated infections Fact Sheet, hundreds of millions of patients are affected by HAIs worldwide each year. The aforementioned factors are attributed to the market growth over the forecast period. In 2020, the outbreak of COVID-19 caused by the novel coronavirus (SARS-CoV-2) has shown a positive impact on the market growth owing to the increasing usage of blood pressure monitors as well as increasing concerns about cross-contamination events caused due to coronavirus.

Gather more insights about the market drivers, restrains and growth of the Global Disposable Blood Pressure Cuffs market

Reusable blood pressure cuffs are known to be among the primary sources of cross-contamination and facilitate the spread of COVID-19 infection and other healthcare-associated infections in healthcare settings. The use of disposable cuffs has been found to reduce the risk of healthcare-associated infections in several healthcare settings, thereby favoring the adoption of these devices. In addition, the need to control the spread of COVID-19 infection is anticipated to create huge growth opportunities for market players. For instance, in July 2020, Vancouver Coastal Health (regional health authority) swapped its reusable BP cuffs with disposable ones to limit the spread of COVID-19 infections, thereby increasing the demand for disposable blood pressure cuffs by its affiliated members. With such increasing demand for these devices globally, the market is projected to have significant growth during the forecast period.

Rising cases of HAIs are another significant factor anticipated to propel market growth during the forecast period. According to a World Health Organization (WHO) report, out of every 100 hospitalized patients, 7 in developed and 10 in developing countries will acquire at least one HAIs. In addition, roughly 30% of patients in ICU are affected by at least one HAIs in high-income countries. Similarly, as per a report published by the European Centre for Disease Prevention and Control (ECDC) in 2018, the prevalence of HAIs in European countries was around 7.1%. It was also reported that around 4,131,000 patients suffer from HAIs each year in Europe. Such cases are expected to increase the demand for disposable BP cuffs. Hence, hospitals and other healthcare facilities are seeking the adoption of disposable BP cuffs to curb the infection rate in medical facilities. Thereby contributing towards the market growth.

Moreover, the rising elderly population in both developed and developing nations is further promoting the market growth. For instance, World Population Prospects of 2019 stated that by 2050, 1 in 6 people will be over the age of 65, up from 1 in 11 in 2019. According to the estimates published by the United Nations in 2019, there were 703 million individuals aged 65 years or above worldwide 2019, and this number is projected to double to 1.5 billion by 2050. During 2019 and 2050, 9 out of 10 countries with the largest percentage point increase in the share of older persons in the world will be in Eastern and South-Eastern Asia. For instance, Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the country. As the growing aging population is more susceptible to chronic conditions such as diabetes, cardiovascular disorders, and hypertension, therefore, are expected to bolster market growth during the forecast period.

Additionally, high blood pressure has been anticipated to be a major risk factor for hemorrhagic stroke and coronary heart diseases in this decade. According to World Health Organization (WHO), around one in four men and one in five women live with hypertension. The World Health Organization (WHO) also states that hypertension is more prevalent in low- and middle-income countries, for instance, the African region has the highest prevalence of hypertension (27%), and North America has the lowest (18%). Hypertension, besides being the most prevalent, is also the leading cause of cardiovascular disease, premature mortality, and disability. It poses a significant economic burden. All the aforementioned facts are expected to drive growth in the near future. Nature Review states that awareness pertaining to hypertension and its treatment & management is significantly low in middle-income countries.

The U.S. dominated the market with the highest shares of 88.71% in 2021. Government initiatives to encourage the adoption of disposable medical supplies in order to prevent infections in healthcare facilities is the key factor responsible for the growth of the market in this country. Moreover, the high prevalence of hypertension, coupled with high expenditure to manage the condition, is anticipated to drive market growth in the country.

According to the Centers for Disease Control and Prevention (CDC), nearly 116 million or 47% of adults in the country had hypertension in 2019, and high BP was the primary cause of death for around 516,955 U.S. residents in the same year. These factors are expected to drive the market growth during the forecast period.

Furthermore, advancement such as the availability of disposable BP cuffs in different sizes and colors for accurate BP readings is anticipated to drive the market growth. Manufacturers refocused on the development of cost-effective, innovative, and easy-to-use products. The improvement in BP cuffs such as Flexiport BP Cuffs by Welch Allyn is expected to boost the usage rates in the coming years. These BP cuffs do not have connectors & traditional cuff tubes and are easy to handle. The attached benefits of the use of these cuffs are presumed to fuel the market demand during the forecast period.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Deep Brain Stimulation Devices Market – The global deep brain stimulation devices market size was valued at USD 1.05 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2022 to 2030.

  • Oral Solid Dosage Contract Manufacturing Market – The global oral solid dosage contract manufacturing market size was valued at USD 31.9 billion in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 6.0% over the forecast period.

Disposable Blood Pressure Cuffs Market Segmentation

Grand View Research has segmented the global disposable blood pressure cuffs market based on call point, product type, and region:

Disposable Blood Pressure Cuffs Call Point Outlook (Revenue, USD Million, 2017 – 2030)

  • Physicians
  • Clinicians
  • Surgeons

Disposable Blood Pressure Cuffs Product Type Outlook (Revenue, USD Million, 2017 – 2030)

  • Neonate Disposable Blood Pressure Cuffs
  • Adult Disposable Blood Pressure Cuffs

Disposable Blood Pressure Cuffs Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)


Market Share Insights

  • November 2018: SunTech Medical- a manufacturer of BP monitoring products, launched Small Adult PLUS BP cuff which could reduce inaccuracies in BP measurement. These cuffs are available in disposable, vinyl, or durable materials.


Key Companies profiled:

Some of the prominent players in the global disposable blood pressure cuffs market include

  • GE Healthcare
  • Philips
  • SunTech Medical, Inc.
  • Omron Healthcare, Inc.
  • Spacelabs Healthcare Inc.
  • American Diagnostic Corporation
  • Hill-Rom Services
  • Midmark
  • Cardinal Health
  • Medline Industries


Order a free sample PDF of the Disposable Blood Pressure Cuffs Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Surgical Instruments Tracking Systems Market: Segment is Also Expected To Witness The Fastest Growth Rate Over The Forecast Period

Surgical Instruments Tracking Systems Industry Overview

The global surgical instruments tracking systems market size was valued at USD 187.67 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. The market growth is driven by the need to automatically track critical equipment, such as surgical instruments, comply with the U.S. Food & Drug Administration (FDA)’s Unique Device Identification (UDI) program, ensure the right tools are available in time for each surgical procedure, and improve patient outcomes. The growing number of surgical procedures, owing to sports injuries, accidents, and cardiac surgeries, due to the increased frequency of cardiovascular illnesses and other chronic disorders, where surgery is mandatory, is driving the market.

Furthermore, emerging economies like India and China, as well as countries in the Middle East, Latin America, and Southeast Asia, are likely to provide major growth possibilities for surgical instrument tracking systems manufacturers. Growing healthcare spending and increasing healthcare infrastructure are likely to provide growth possibilities for market players in these economies. Surgical instrument tracking systems facilitate automatic identification of medical devices including instruments to adhere to the U.S. FDA’s new Unique Device Identification (UDI) tracking requirements. As the number of devices falling under UDI will keep expanding, it is expected to fuel the demand for solutions that enable compliance, such as surgical instrument tracking systems. Several other government bodies have also specified regulatory requirements related to traceability from manufacturer to patient.

Gather more insights about the market drivers, restrains and growth of the Global Surgical Instruments Tracking Systems market

These include the CFDA’s draft of UDI regulation in China, the EU’s In Vitro Diagnostic Medical Device Regulation 2017/746 and Medical Device Regulation 2017/745, and Australia and New Zealand’s AS/NZS 4187:2014. This is expected to propel the adoption of automatic identification and tracking technologies including surgical instrument tracking systems. For instance, Xerafy Singapore Pte. Ltd. offers RFID Systems for Healthcare that helps comply with such regulations. The COVID-19 pandemic significantly impacted the market. According to a 2020 report by Censis Technologies, Inc., many elective surgeries were postponed due to the pandemic. However, when they resumed, Operating Rooms (ORs) and technicians had to deal with a huge backlog, while continuing to work around COVID.

This unveiled the need for effective surgical instrument tracking systems as sterile supply processing and equipment shortages became an issue. Many large hospitals experience several incidences of surgical items left inside patients after surgery. These could vary from clamps and sponges to needles and other items. Responding to these mistakes can be very costly. Typically, after surgery, a team may conduct careful counts manually to ensure the post-op inventory of instruments and materials is the same as before the operation. In case the numbers don’t match, costly x-rays must be taken to look for stray instruments, which could add to complications. Such Significant incidences are other factors contributing to the market growth.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Oncology Information Systems Market – The global oncology information systems market was valued at USD 2.5 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.9% from 2023 to 2030.

  • Fitness Tracker Market – The global fitness tracker market size to be valued at USD 138.7 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of 18.9% during the forecast period.

Surgical Instruments Tracking Systems Market Segmentation

Grand View Research has segmented the global surgical instruments tracking systems market based on product, technology, end use, and region:

Surgical Instrument Tracking Systems Product Outlook (Revenue, USD Million, 2017 – 2030)

  • Hardware
  • Software
  • Services

Surgical Instrument Tracking Systems Technology Outlook (Revenue, USD Million, 2017 – 2030)

  • Barcodes
    • Hospitals
    • Others
  • RFID
    • Hospitals
    • Others

Surgical Instrument Tracking Systems End-use Outlook (Revenue, USD Million, 2017 – 2030)

  • Hospitals
  • Others

Surgical Instrument Tracking Systems Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • October 2020: STERIS plc acquired Key Surgical, thus expanding its sterile processing, OR, and endoscopy offerings. This also added the latter’s KeyDot surgical instrument tracking solution to STERIS’ portfolio.


Key Companies profiled:

Some of the prominent players in the global surgical instruments tracking systems market include:

  • Censis Technologies, Inc. (Fortive)
  • SpaTrack Medical Ltd.
  • Xerafy Singapore Pte Ltd.
  • Fingerprint Medical Ltd.
  • Getinge AB
  • B. Braun Melsungen AG
  • BD
  • Haldor Advanced Technologies
  • Microsystems, Inc.
  • Ternio Group LLC

Order a free sample PDF of the Surgical Instruments Tracking Systems Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Digital Therapeutics Market: Asia Pacific Region is Expected To Expand At The Fastest Growth Rate

Digital Therapeutics Industry Overview

The global digital therapeutics market size was valued at USD 4.20 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 26.1% from 2022 to 2030. Increasing smartphone penetration in developed & developing countries, the cost-effectiveness of digital health technology for providers & patients, and increasing demand for integrated healthcare systems & patient-centric care are expected to drive the market. According to Kepios, in April 2021, there were 4.27 billion internet users globally, which is over 60% of the global population. As this number increases, the awareness about smart health tracking is expected to improve. Furthermore, the COVID-19 pandemic, supportive regulatory initiatives & early signs of reimbursement, and increasing prevalence of chronic diseases are also anticipated to fuel the market growth.

The COVID-19 pandemic significantly impacted the market. A major COVID-related driver is a rise in demand for convenient and accessible digital health solutions. The April 2020 guidelines released by the FDA stated that for the duration of the pandemic, it will allow the distribution and use of digital health therapeutic devices for mental health disorders. Providers can, thus, commercialize their solutions without complying with usual regulatory requirements, provided the devices do not create any undue public health emergency. Growing regulatory initiatives are anticipated to propel the standardization and R&D in the market over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Digital Therapeutics market

For instance, the Software Pre-Cert Pilot Program is part of the Digital Health Innovation Action Plan of the FDA, intended for a more efficient regulatory oversight of Software-based Medical Devices (SaMD) developed by manufacturers. The program is aimed at developing an efficient regulatory oversight for assessing organizations to establish trust that they can develop high-quality SaMD products. As per the CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have 2 or more chronic diseases. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer’s have been identified as the leading causes of death and disability in the country.

Poor nutrition, use of tobacco, alcoholism, and lack of physical exercise further increase the risk of developing a chronic disease. Healthcare costs are impacted exponentially as most chronic diseases do not exist in isolation and a patient often suffers from co-morbidities. Smartphone ownership is even becoming essential with improving global interconnectivity, economically and socially. Smartphone penetration is an important factor related to the growth of the market.


Browse through Grand View Research’s 
Healthcare IT Industry Research Reports.

  • Electronic Data Capture Systems Market – The global electronic data capture systems market size was valued at USD 1.25 billion in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2030.
  • E-Prescribing Market – The global e-prescribing market size was estimated at USD 2.89 billion in 2022 and it is anticipated to witness a compound annual growth rate (CAGR) of 26.8% during the forecast period.

Digital Therapeutics Market Segmentation

Grand View Research has segmented the Digital therapeutics market on the basis of application, end user, and region:

Digital Therapeutics Application Outlook (Revenue, USD Million, 2017 – 2030)

  • Diabetes
  • Obesity
  • CVD
  • Respiratory Diseases
  • Smoking Cessation
  • CNS Diseases
  • Others

Digital Therapeutics End-user Outlook (Revenue, USD Million, 2017 – 2030)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Digital Therapeutics Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • December 2021: Teladoc expanded its partnership with the National Labor Alliance for offering its full suite of virtual care products and services. These products and services included specialty care, general medical, expert medical services, mental health, virtual primary care programs, and chronic condition management.


Key Companies profiled:

Some of the key players in the global digital therapeutics market include:

  • OMADA HEALTH, INC.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Teladoc Health, Inc.
  • Propeller Health (ResMed)
  • Fitbit LLC
  • CANARY HEALTH
  • Noom, Inc. 
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth Corp.
  • BigHealth 
  • GAIA AG
  • Limbix Health, Inc. 

Order a free sample PDF of the Digital Therapeutics Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Breastfeeding Accessories Market: Disposable Gowns Held The Second-Largest Revenue Share

Breastfeeding Accessories Industry Overview

The global breastfeeding accessories market size was valued at USD 2.22 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.45% from 2022 to 2030. The demand for breastfeeding accessories is increasing owing to a rise in the global women’s employment rate. Furthermore, an increase in awareness campaigns by government and market players regarding the availability of breastfeeding accessories is anticipated to impel the market growth during the forecast period. For instance, various market players such as Medela LLC, Laura & Co., Newell Brands, and Ameda, along with universities including Washington University and Fudan University are raising awareness among women regarding breastfeeding and its benefits by arranging campaigns and providing informative magazines. In addition, social media platforms such as YouTube, Facebook, and Instagram have enabled individuals to access information about breastfeeding and related accessories.

Similarly, an increasing number of milk banks around the globe is predicted to propel market growth further. Due to the high demand for breast milk storage, the number of milk banks is increasing. Milk banks are beneficial for mothers and are considered a progressive initiative. If the mother is infected and there is a risk of disease transmission, the mother is unable to lactate, or the baby is orphaned, milk banks can offer major advantages. Thus, an increase in the number of milk banks may increase the use of breastfeeding accessories, thereby driving the market over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Breastfeeding Accessories market

Moreover, the presence of favorable demographics such as the growing global birth rate in emerging and underdeveloped nations provides opportunities for the market players to expand their presence in these countries. For instance, as per the Centers for Disease Control and Prevention, the birth rate in the U.S. has reached 11 per 1,000 population, with a fertility rate of 56.0 births per 1,000 women (aged 15 – 44). The increase in the number of births is anticipated to increase the use of breastfeeding accessories, thereby boosting the market growth over the forecast period.

Even though COVID-19 had an adverse impact on the market, the use of breastfeeding accessories is expected to increase during the post-pandemic period. The COVID-19 vaccine has been introduced globally, as a result, countries have opened their international borders, due to which the supply chain is expected to normalize during the post-pandemic period. Furthermore, the birth rate is expected to increase post-pandemic. For instance, researchers at the University of Michigan predict an increase in the number of births post-pandemic. Hence, the market is expected to witness a gradual surge in demand for breastfeeding accessories.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Tumor Ablation Market – The global tumor ablation market size was valued at USD 1.14 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2022 to 2030.
  • eHealth Devices Market – The global eHealth devices market size was valued at USD 15.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.4% from 2022 to 2028.

Breastfeeding Accessories Market Segmentation

Grand View Research has segmented the global breastfeeding accessories market on the basis of product and region:

Breastfeeding Accessories Product Outlook (Revenue, USD Million, 2018 – 2030)

  • Nipple Care Products
  • Breast Shells
  • Breast Pads
  • Breastmilk Preparation and Cleaning Products
  • Breastmilk Storage and Feeding
    • Coolers
    • Others
  • Perineal Cooling Pads
  • Breast Heating Pads
  • Breast Cooling Pads
  • Baby Weighing Scales
  • Maternity/Nursing Bras
  • Nursing Tank Tops
  • Lactation Massager
  • Breast Pump Carry/Tote Bags
  • Postpartum Recovery Accessories
    • Disposable Gowns
    • Nursing Pillow
    • Others

Breastfeeding Accessories Regional Outlook (Revenue, USD Million, 2018 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • August 2021: Medela AG introduced a new silicone breastmilk collector in North America. This product was designed to help lactating mothers minimize milk loss and increase the company’s market share in North America.

Key Companies profiled:

Some prominent players in the global breastfeeding accessories market include:

  • Medela AG
  • Ameda, Inc.
  • Willow Innovations, Inc.
  • Koninklijke Philips N.V.
  • Chiaro Technology Limited
  • Pigeon Corporation
  • Spectra Baby
  • Lavie Mom
  • Motif Medical
  • Mayborn Group Limited

Order a free sample PDF of the Breastfeeding Accessories Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Medical Device Analytical Testing Outsourcing Market is Projected To Expand Further At A Significant CAGR Over The Forecast Period

Medical Device Analytical Testing Outsourcing Industry Overview

The global medical device analytical testing outsourcing market size was valued at USD 5.0 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.1% over the forecast period. The key factors driving the market are complexity in product design, increased competition, an increase in the number of small-scale manufacturers of medical devices, and strict approval norms. The COVID-19 pandemic has emphasized the significance of developing novel low-cost medical equipment. This crisis has resulted in a global economic and health pandemic. As a result, several enterprises have shut down their manufacturing facilities and halted the majority of the manufacturing process.

Medical device TIC services have always been on the rise since they serve a crucial role in protecting consumers worldwide from hazardous and low-quality medical device products. For example, the demand for masks has increased as a result of COVID-19, and several countries have released appropriate specifications, such as UNE 0064-1, UNE 0065, and UNE 0064-2. Pricing pressure exists in developed countries, such as the U.S., thus operators are seeking ways to reduce costs throughout the value chain. On the other hand, the real potential resides in developing economies. However, developing regions are likely to be price-sensitive.

Gather more insights about the market drivers, restrains and growth of the Global Medical Device Analytical Testing Outsourcing market

As a result, market players are working hard to cut the overall cost of gadgets. Outsourcing analytical testing processes allows businesses to focus on product development and marketing initiatives. The COVID-19 pandemic has created a devastating impact on the healthcare industry. However, the market witnessed a considerably minimal negative impact in 2020 compared to other business domains. Moreover, the market even witnessed a significant surge in its growth rate in 2021, owing to the increasing focus on analytical testing of medical devices for COVID-19 infection.

The regulatory authorities also conduct routine post-market surveillance by charging the manufacturers a fee. The receipt of any complaints regarding the product’s flaws results in its removal from the market, demonstrating the stringency of these procedures. Personalized medicine, drug-device combinations, Artificial Intelligence (AI), wearables, and a greater emphasis on real-time patient monitoring have all resulted in a complicated medical device ecosystem. When it comes to chronic disease management, such as diabetes and Cardiovascular Diseases (CVDs), real-time patient monitoring, remote patient monitoring, and continuous patient monitoring are the primary areas of focus.


Browse through Grand View Research’s 
Medical Devices Industry Research Reports.

  • Guidewires Market – The global guidewires market size was estimated at USD 1.89 billion in 2018 and is projected to expand at a CAGR of 6.3% over the forecast period. Rising preference for minimally invasive surgical procedures owing to advantages such as smaller incisions, faster recovery time, and reduced pain is boosting the growth.
  • Artificial Tendons and Ligaments Market – The global artificial tendons and ligaments market size was estimated at USD 18.8 million in 2018 and is expected to exhibit a CAGR of 11.3% over the forecast period. Increasing incidence of sports injuries is the key factor driving the market.

Medical Device Analytical Testing Outsourcing Market Segmentation

Grand View Research has segmented the global medical device analytical testing outsourcing market based on services, device type, end-use, therapeutic areas, and region:

Medical Device Analytical Testing Outsourcing Services (Revenue, USD Million, 2018 – 2030)

  • Extractable & Leachable
  • Material Characterization
  • Physical Testing
  • Bioburden Testing
  • Sterility Testing
  • Other Tests

Medical Device Analytical Testing Outsourcing Device Type Outlook (Revenue, USD Million, 2018 – 2030)

  • Reprocessed Devices
  • Others

Medical Device Analytical Testing Outsourcing End-use Outlook (Revenue, USD Million, 2018 – 2030)

  • Hospital
  • Others

Medical Device Analytical Testing Outsourcing Therapeutic Areas Outlook (Revenue, USD Million, 2018 – 2030)

  • Cardiology
  • Diagnostic Imaging
  • Orthopedic
  • IVD
  • Ophthalmin
  • General & Plastic Surgery
  • Drug Delivery
  • Endoscopy
  • Dental
  • Diabetes Care
  • Others

Medical Device Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2018 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)


Market Share Insights

  • November 2018: the company opened its new medical device testing center in Suzhou, China.  The new medical device testing center occupies a 15,000-square-meter facility.


Key Companies profiled:

Some of the prominent players in the global medical device analytical testing outsourcing market include:

  • SGS
  • Toxikon, Inc
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group plc
  • Wuxi AppTec
  • North American Science Associates, Inc.
  • Envigo
  • Charles River Laboratories International, Inc.
  • Medical Device Testing Services


Order a free sample PDF of the Medical Device Analytical Testing Outsourcing Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Latin America Pharmaceutical Contract Manufacturing & Research Services Market: Manufacturing Segment Captured The Largest Share

Latin America Pharmaceutical Contract Manufacturing & Research Services Industry Overview

The Latin America pharmaceutical contract manufacturing and research services market size was valued at USD 19.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. Drug shortfall, tighter budgets, rising competition, patent expiration, and insufficient resources are some of the major factors boosting growth in the market. The time- and cost-saving benefits associated with the implementation of outsourcing are contributing to market growth. The key players are consistently capitalizing on technology, infrastructure, and personnel to gain a bigger share of the outsourcing revenue. Moreover, an increase in collaborations between pharmaceutical companies and outsourcing companies for developing COVID-19 treatments is boosting the market growth.

The ongoing COVID-19 pandemic has positively impacted the contract manufacturing market. As the development of mRNA vaccines and subsequent manufacturing at a global scale to respond to the COVID-19 pandemic represents a leap forward in the production facilities. With increased focus on CDMO activity for commercial supply, the demand for outsourced early phase development services and technology is growing in line with this new generation of molecules.

Moreover, new product launches and novel drug delivery mechanisms that are expected to enter the market in record timelines are anticipated to drive outsourcing demand. The key players entered into strategic partnerships for the development of COVID-19 treatments. For instance, in May 2020, Lonza announced a strategic collaboration agreement for ten years with Moderna to empower the manufacture of Spikevax COVID-19 vaccine and further Moderna Services in the future.

Gather more insights about the market drivers, restrains and growth of the Latin America Pharmaceutical Contract Manufacturing & Research Services market

Furthermore, the shift from cost control to value-added solutions, the introduction of novel technologically equipped facilities, and risk-sharing between pharma and CMOs are expected to serve as drivers. Companies have started financing efforts to meet the snowballing demand for biological drugs, which in turn, leads to a surge in the development of pharmaceutical products. This steady commercial success of biopharmaceuticals is expected to accelerate the growth of the Latin America pharmaceutical contract manufacturing & research services market over the forecast period.

Biopharmaceuticals Manufacturing is recognized as a leading sector in terms of growth potential. Many healthcare entities believe that this sector would be one of the top 10 revenue generators in the forthcoming years. Moreover, the market players are making continuous efforts for the development of this sector to meet the increasing demand for bio-based pharmaceuticals, which in turn, is anticipated to result in a surge of CMOs for biopharmaceutical production. This healthy growth of biopharmaceuticals has resulted in the development of a large Service pipeline.

Understanding the cost-effectiveness associated with contract manufacturing, many firms have begun to outsource parts of their biopharmaceutical manufacturing to contract manufacturers. Furthermore, in-house R&D at biopharmaceutical majors is no longer the sole source of successful innovation in the industry, with novel molecules discovered by small-to-mid capital companies before being acquired by established players. As a consequence, CROs have increasingly begun to highlight contract wins with such smaller biotech entities as an important driver of sustainability in volumes.

Latin American companies are enhancing their global market presence by investing efforts in the modification and expansion of domestic specialty manufacturing facilities as well as focusing on worldwide partnerships. On the other hand, the expansion of international and well-established companies, such as Pharmaceutical Product Development Inc (PPD) and QuintilesIMS, in countries like Brazil, Mexico, Argentina, and Chile is expected to fuel growth in Latin American pharmaceutical contract manufacturing & research services market. These countries are perceived to have great potential for pharmaceutical development.


Browse through Grand View Research’s Medical Devices Industry Research Reports.

  • Anastomosis Devices Market – The global anastomosis devices market size was valued at USD 3.58 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030.

  • Skincare Devices Market – The global skincare devices market size was valued at USD 12.5 billion in 2021 and is anticipated to witness a compound annual growth rate (CAGR) of 11.9% from 2022 to 2030.

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Segmentation

Grand View Research has segmented the Latin America pharmaceutical contract manufacturing & research services market based on services and country:

Latin America Pharmaceutical Contract Manufacturing & Research Services Outlook (Revenue, USD Million, 2018 – 2030)

  • Manufacturing
    • API/Bulk Drugs
    • Advanced Drug Delivery Formulations Packaging
    • Packaging
    • Finished Dose Formulations
      • Solid Formulations
      • Liquid Formulations
      • Semi-solid Formulations
  • Research
    • Oncology
    • Vaccines
    • Inflammation & Immunology
    • Cardiology
    • Neuroscience
    • Others

Latin America Pharmaceutical Contract Manufacturing & Research Services Regional Outlook (Revenue, USD Million, 2018 – 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the Latin America pharmaceutical contract manufacturing & research services market include:

  • Boehringer Ingelheim GmbH
  • Lonza
  • Pfizer, Incorporated. (Pfizer CenterOne)
  • Charles River Laboratories International, Inc
  • Albany Molecular Research, Inc
  • Covance, Inc. (LabCorp)
  • QuintilesIMS
  • Pharmaceutical Service Development, LLC
  • Recipharm AB
  • AbbVie, Inc.

Order a free sample PDF of the Latin America Pharmaceutical Contract Manufacturing & Research Services Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter